Search This Blog

Thursday, May 7, 2020

Magenta Therapeutics EPS beats by $0.12

Magenta Therapeutics (NASDAQ:MGTA): Q1 GAAP EPS of -$0.51 beats by $0.12.
Cash, equivalents and marketable securities of $130.41M (-10.5% Q/Q)
Press Release
https://seekingalpha.com/news/3571159-magenta-therapeutics-eps-beats-0_12
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)